Drug Trial Radar · NCT06029439
Study to Assess the Safety and Effectiveness of NMRA-335140-501
Last checked: Nov 20, 2026Latest source record: Sep 14, 2026 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Terminated
Enrollment
904
Actual
Start
Nov 10, 2023
Primary completion
Aug 17, 2026
Study completion Aug 17, 2026
Sponsor
- Lead sponsor
- Neumora Therapeutics, Inc.Industry
- Sponsor type
- Industry
- First posted
- Sep 8, 2023
Design
- Study type
- Interventional
- Phase
- Phase 3
- Allocation
- Not applicable (single group)
- Model
- Single group
- Masking
- None
- Primary purpose
- Treatment
- FDA-regulated drug
- Yes
- Who can join
- All sexes, from 18 years, up to 65 years
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
This is a 52-week open-label extension (OLE) study that will evaluate the safety, tolerability, and effectiveness of NMRA-335140 in participants with major depressive disorder (MDD). Participants who completed a parent study investigating the efficacy and safety of NMRA-335140 as a treatment for MDD (ie, NMRA-335140-301, NMRA-335140-302, or NMRA-335140-303), and complete the 6 weeks double-blind treatment, provide informed consent, and meet eligibility criteria, may enter this extension study.
Conditions
- Major Depressive Disorder
Interventions
NMRA-335140Drug
Participants will receive NMRA-335140 at a dose of 80 mg once daily (QD), orally during a 52-week treatment period.
Primary outcomes
What the sponsor says the trial is designed to measure.
- Safety and tolerability assessments based on Treatment Emergent Adverse Events (TEAEs) and validated clinical scalesTime frame: Up to 54 Weeks
Locations
178 sites in 11 countries. Site status is shown where the registry gives one.
Neumora Investigator site
Huntsville, Alabama
Neumora Investigator Site
Phoenix, Arizona
Neumora Investigator Site
Bentonville, Arkansas
Neumora Investigator Site #1
Little Rock, Arkansas
Neumora Investigator site
Little Rock, Arkansas
Neumora Investigator Site
Rogers, Arkansas
Neumora Investigator site
Bellflower, California
Neumora Investigator Site
Cerritos, California
Neumora Investigator Site
Encino, California
Neumora Investigator Site
Garden Grove, California
Neumora Investigator Site
Glendale, California
Neumora Investigator Site
Imperial, California
Neumora Investigator Site
Irvine, California
Neumora Investigator Site
Lafayette, California
Neumora Investigator Site #1
Long Beach, California
Neumora Investigator site
Long Beach, California
Neumora Investigator Site
Los Angeles, California
Neumora Investigator Site
Newport Beach, California
Neumora Investigator Site
Oceanside, California
Neumora Investigator Site #1
Orange, California
Neumora Investigator Site
Orange, California
Neumora Investigator Site
Riverside, California
Neumora Investigator Site
San Diego, California
Neumora Investigator Site
San Francisco, California
Neumora Investigator Site
San Jose, California
Neumora Investigator Site
Santa Ana, California
Neumora Investigator Site
Sherman Oaks, California
Neumora Investigator Site
Temecula, California
Neumora Investigator Site
Torrance, California
Neumora Investigator Site
Colorado Springs, Colorado
Neumora Investigator Site
New Haven, Connecticut
Neumora Investigator Site
Norwalk, Connecticut
Neumora Investigator Site
Bradenton, Florida
Neumora Investigator Site
Brandon, Florida
Neumora Investigator Site
Gainesville, Florida
Neumora Investigator Site
Hallandale, Florida
Neumora Investigator Site
Hialeah, Florida
Neumora Investigator Site
Hialeah, Florida
Neumora Investigator Site
Hollywood, Florida
Neumora Investigator Site
Jacksonville, Florida
Showing 40 of 178 sites, US sites first. The full list is on the registry record.
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.